drugset / Trial / NCT00316927

Dexamethasone, Aspirin, and Diethylstilbestrol in Treating Patients With Locally Advanced or Metastatic Prostate Cancer

NCT00316927 ↗

Phase 3 Completed 260 enrolled St. Bartholomew's Hospital
RandomizedTreatment

Summary

RATIONALE: Giving dexamethasone together with aspirin and diethylstilbestrol may be effective in lowering prostate-specific antigen levels and may slow or stop the growth of prostate cancer. It is not yet known which schedule of dexamethasone, aspirin, and diethylstilbestrol is more effective in treating prostate cancer. PURPOSE: This randomized phase III trial is studying dexamethasone and aspirin when given together with two different schedules of diethylstilbestrol to compare how well they work in treating patients with locally advanced or metastatic prostate cancer.

Timeline

Start
2002-12
Primary completion
—
Completion
2007-04

Outcome

Missed primary endpoint

paper Dexamethasone and immediate Diethylstilbestrol resulted in neither higher PSA response rate nor higher PFS compared with Dexamethasone with deferred Diethylstilbestrol. PMID 21285990 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Diethylstilbestrol Small molecule — Oral
Background Aspirin Small molecule — Oral
Background Dexamethasone Small molecule — Oral

Indications